お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
920498

統制薬物の世界市場:産業分析、市場規模・シェア・成長率・動向・予測 (2019~2027年)

Controlled Substance Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版日: | 発行: Transparency Market Research | ページ情報: 英文 206 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.77円
統制薬物の世界市場:産業分析、市場規模・シェア・成長率・動向・予測 (2019~2027年)
出版日: 2019年11月13日
発行: Transparency Market Research
ページ情報: 英文 206 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の統制薬物の市場について分析し、市場の基本構造や主な影響要因、市場規模の動向見通し (過去2年間・今後9年間分)、薬物別・用途別・流通チャネル別および地域別・主要国の詳細動向、競争環境 (市場シェア構造)、主要企業のプロファイルなどを調査しております。

第1章 序論

第2章 前提条件・分析手法

第3章 エグゼクティブサマリー:世界の統制薬物市場

第4章 市場概要

  • イントロダクション
    • クラスの定義
    • 業界の沿革/発展
  • 概要
  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • 市場の分析と予測 (通算11年間分)
    • 市場規模の予測 (金額ベース)

第5章 市場の展望

  • パイプライン分析
  • 主な企業合併・買収 (M&A)
  • 規制シナリオ

第6章 世界の統制薬物市場の分析と予測:薬物別

  • イントロダクション・定義
  • 分析概略/市場動向
  • 市場規模の予測:薬物別 (金額ベース、通算11年間分)
    • オピオイド
      • コデイン
      • モルヒネ
      • フェンタニル
      • ヒドロコドン
      • トラマドール
      • オキシコドン
      • その他
    • 精神刺激剤
      • アンフェタミン
      • メチルフェニデート
      • デキストロアンフェタミン
      • メタンフェタミン
      • モダフィニル
      • その他
    • 鎮静剤
      • バルビツール酸系
      • ベンゾジアゼピン
    • カンナビノイド
  • 市場求心力:薬物別

第7章 世界の統制薬物市場の分析と予測:用途別

  • イントロダクション・定義
  • 分析概略/市場動向
  • 市場規模の予測:用途別 (金額ベース、通算11年間分)
    • ADHD
    • 疼痛管理
    • うつ病
    • 睡眠障害
    • 鎮咳薬
    • 不安症
    • てんかん
    • その他
  • 市場求心力:用途別

第8章 世界の統制薬物市場の分析と予測:流通チャネル別

  • イントロダクション・定義
  • 分析概略/市場動向
  • 市場規模の予測:流通チャネル別 (金額ベース、通算11年間分)
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場求心力:流通チャネル別

第9章 世界の統制薬物市場の分析と予測:地域別

  • 分析概略
  • 市場規模の予測:地域別 (金額ベース、通算11年間分)
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場求心力:地域別

第8章 北米の統制薬物市場の分析と予測

  • イントロダクション
    • 分析概略
  • 市場規模の予測:薬物別 (金額ベース、通算11年間分)
  • 市場規模の予測:用途別 (金額ベース、通算11年間分)
  • 市場規模の予測:流通チャネル別 (金額ベース、通算11年間分)
  • 市場規模の予測:国/地域別 (金額ベース、通算11年間分)
    • 北米、カナダ
  • 市場求心力の分析:薬物別・用途別・流通チャネル別・国別

第11章 欧州の統制薬物市場の分析と予測

  • 市場規模の予測:国/地域別 (金額ベース、通算11年間分)
    • ドイツ、英国、フランス、イタリア、スペインなど

第12章 アジア太平洋地域の統制薬物市場の分析と予測

  • 市場規模の予測:国/地域別 (金額ベース、通算11年間分)
    • 中国、日本、インド、オーストラリア・ニュージーランドなど

第13章 ラテンアメリカの統制薬物市場の分析と予測

  • 市場規模の予測:国/地域別 (金額ベース、通算11年間分)
    • ブラジル、メキシコなど

第14章 中東・アフリカの統制薬物市場の分析と予測

  • 市場規模の予測:国/地域別 (金額ベース、通算11年間分)
    • 湾岸協力会議 (GCC) 諸国、南アフリカなど

第15章 競争環境

  • 市場参入企業:市場競争マトリックス (階層別・企業規模別)
  • 市場ポジショニング/ランキング分析:企業別
  • 企業プロファイル
    • F. Hoffmann-La Roche AG
      • 企業概要 (本社所在地、事業部門、従業員数)
      • 財務分析
      • 成長戦略
      • SWOT分析
    • AbbVie, Inc.
    • Mallinckrodt plc
    • Pfizer, Inc.
    • Sun Pharmaceutical Ltd.
    • Ampac Fine Chemicals
    • GW Pharmaceuticals plc
    • Merck & Co., Inc.
図表

List of Tables

  • Table 01: Global Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 02: Global Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017-2027
  • Table 03: Global Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017-2027
  • Table 04: Global Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017-2027
  • Table 05: Global Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 06: Global Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 07: Global Controlled Substance Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 08: North America Controlled Substance Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 09: North America Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 10: North America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017-2027
  • Table 11: North America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017-2027
  • Table 12: North America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017-2027
  • Table 13: North America Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 14: North America Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 15: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 16: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 17: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017-2027
  • Table 18: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017-2027
  • Table 19: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017-2027
  • Table 20: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 21: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 22: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 23: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 24: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017-2027
  • Table 25: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017-2027
  • Table 26: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017-2027
  • Table 27: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 28: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 29: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 30: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 31: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017-2027
  • Table 32: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017-2027
  • Table 33: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017-2027
  • Table 34: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 35: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 36: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 37: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 38: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017-2027
  • Table 39: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017-2027
  • Table 40: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017-2027
  • Table 41: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 42: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027

List of Figures

  • Figure 01: Global Controlled Substance Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
  • Figure 02: Market Opportunity Map, by Drug Type, 2018
  • Figure 03: Global Controlled Substance Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 04: Global Controlled Substance Market Value Share, by Drug (2018)
  • Figure 05: Global Controlled Substance Market Value Share, by Application (2018)
  • Figure 06: Global Controlled Substance Market Value Share, by Distribution Channels (2018)
  • Figure 07: Global Controlled Substance Market Value Share, by Region (2018)
  • Figure 08: Global Controlled Substance Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 09: Global Controlled Substance Market Revenue (US$ Mn) by Opioids, 2017-2027
  • Figure 10: Global Controlled Substance Market Revenue (US$ Mn) by Stimulants, 2017-2027
  • Figure 11: Global Controlled Substance Market Revenue (US$ Mn) by Depressants, 2017-2027
  • Figure 12: Global Controlled Substance Market Revenue (US$ Mn) by Cannabinoids, 2017-2027
  • Figure 13: Global Controlled Substance Market Attractiveness Analysis, by Drug, 2019-2027
  • Figure 14: Global Controlled Substance Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 15: Global Controlled Substance Market Value (US$ Mn), by ADHD, 2017-2027
  • Figure 16: Global Controlled Substance Market Value (US$ Mn), by Pain Management, 2017-2027
  • Figure 17: Global Controlled Substance Market Value (US$ Mn), by Depression, 2017-2027
  • Figure 18: Global Controlled Substance Market Value (US$ Mn), by Sleep Disorder, 2017-2027
  • Figure 19: Global Controlled Substance Market Value (US$ Mn), by Cough Suppression, 2017-2027
  • Figure 20: Global Controlled Substance Market Value (US$ Mn), by Anxiety, 2017-2027
  • Figure 21: Global Controlled Substance Market Value (US$ Mn), by Seizure, 2017-2027
  • Figure 22: Global Controlled Substance Market Value (US$ Mn), by Others, 2017-2027
  • Figure 23: Global Controlled Substance Market Attractiveness, by Application, 2019-2027
  • Figure 24: Global Controlled Substance Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 25: Global Controlled Substance Market Revenue (US$ Mn) by Hospital Pharmacies, 2017-2027
  • Figure 26: Global Controlled Substance Market Revenue (US$ Mn) Retail Pharmacies, 2017-2027
  • Figure 27: Global Controlled Substance Market Revenue (US$ Mn) Online Pharmacies, 2017-2027
  • Figure 28: Global Controlled Substance Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 29: Global Controlled Substance Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 30: Global Controlled Substance Market Attractiveness Analysis, by Region, 2019-2027
  • Figure 31: North America Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2027
  • Figure 32: North America Controlled Substance Market Value Share, by Country, 2018 and 2027
  • Figure 33: North America Controlled Substance Market Attractiveness, by Country, 2019-2027
  • Figure 34: North America Controlled Substance Market Value Share, by Drug, 2018 and 2027
  • Figure 35: North America Controlled Substance Market Attractiveness, by Drug, 2019-2027
  • Figure 36: North America Controlled Substance Market Value Share, by Application, 2018 and 2027
  • Figure 37: North America Controlled Substance Market Attractiveness, by Application, 2019-2027
  • Figure 38: North America Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 39: North America Controlled Substance Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 40: Europe Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2027
  • Figure 41: Europe Controlled Substance Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 42: Europe Controlled Substance Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 43: Europe Controlled Substance Market Value Share, by Drug, 2018 and 2027
  • Figure 44: Europe Controlled Substance Market Attractiveness, by Drug, 2019-2027
  • Figure 45: Europe Controlled Substance Market Value Share, by Application, 2018 and 2027
  • Figure 46: Europe Controlled Substance Market Attractiveness, by Application, 2019-2027
  • Figure 47: Europe Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 48: Europe Controlled Substance Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 49: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2027
  • Figure 50: Asia Pacific Controlled Substance Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 51: Asia Pacific Controlled Substance Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 52: Asia Pacific Controlled Substance Market Value Share, by Drug, 2018 and 2027
  • Figure 53: Asia Pacific Controlled Substance Market Attractiveness, by Drug, 2019-2027
  • Figure 54: Asia Pacific Controlled Substance Market Value Share, by Application, 2018 and 2027
  • Figure 55: Asia Pacific Controlled Substance Market Attractiveness, by Application, 2019-2027
  • Figure 56: Asia Pacific Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 57: Asia Pacific Controlled Substance Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 58: Latin America Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2027
  • Figure 59: Latin America Controlled Substance Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 60: Latin America Controlled Substance Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 61: Latin America Controlled Substance Market Value Share, by Drug, 2018 and 2027
  • Figure 62: Latin America Controlled Substance Market Attractiveness, by Drug, 2019-2027
  • Figure 63: Latin America Controlled Substance Market Value Share, by Application, 2018 and 2027
  • Figure 64: Latin America Controlled Substance Market Attractiveness, by Application, 2019-2027
  • Figure 65: Latin America Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 66: Latin America Controlled Substance Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 67: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2027
  • Figure 68: Middle East & Africa Controlled Substance Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 69: Middle East & Africa Controlled Substance Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 70: Middle East & Africa Controlled Substance Market Value Share, by Drug, 2018 and 2027
  • Figure 71: Middle East & Africa Controlled Substance Market Attractiveness, by Drug, 2019-2027
  • Figure 72: Middle East & Africa Controlled Substance Market Value Share, by Application, 2018 and 2027
  • Figure 73: Middle East & Africa Controlled Substance Market Attractiveness, by Application, 2019-2027
  • Figure 74: Middle East & Africa Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 75: Middle East & Africa Controlled Substance Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 76: Market Position/Ranking Analysis, 2018, by Tier and Size of the Company
目次

Controlled Substance Market - Scope of the Report

TMR'S report on the global controlled substance market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market for the forecast period of 2019 to 2027. The report provides the overall market revenue of the global controlled substance market for the period of 2017 - 2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global controlled substance market for the forecast period.

The controlled substance market report has been prepared after extensive primary and secondary research. Primary research involves bulk of the research efforts, wherein, analysts carry out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global controlled substance market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of the top-down and bottom-up approach to study various phenomena in the global controlled substance market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study of the controlled substance market. Furthermore, the report sheds light on the changing competitive dynamics in the global controlled substance market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global controlled substance market.

The report delves into the competitive landscape of the global controlled substance market. Key players operating in the global controlled substance market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global controlled substance market that have been profiled in this report.

Key Questions Answered in the Controlled Substance Market Report

What is the sales/revenue generated by each drug across all regions in the controlled substance market during the forecast period?

What are the opportunities in the global controlled substance market?

What are the major drivers, restraints, opportunities, and threats in the controlled substance market?

Which region is likely to expand at the fastest CAGR in the global controlled substance market during the forecast period?

Which controlled substance drug and application segments are expected to generate the highest revenue, globally, in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?

What was the market share or position of different companies operating in the global controlled substance market in 2018?

Global Controlled Substance Market - Research Objectives and Research Approach

The comprehensive report on the global controlled substance market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides a detailed explanation of the objectives behind this study, regulatory scenario, pipeline analysis of upcoming different scheduled drugs for medical use, and key mergers & acquisitions to combat in the market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows the comparison of the market shares of key segments in the past and at the end of the forecast period.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Controlled Substance Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Class Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Controlled Substance Market Analysis and Forecasts, 2017-2027
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

  • 5.1. Pipeline Analysis
  • 5.2. Key Merger & Acquisition
  • 5.3. Regulatory Scenario

6. Global Controlled Substance Market Analysis and Forecasts, by Drug, 2017-2027

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Drug, 2017-2027
    • 6.3.1. Opioids
      • 6.3.1.1. Codeine
      • 6.3.1.2. Morphine
      • 6.3.1.3. Fentanyl
      • 6.3.1.4. Hydrocodone
      • 6.3.1.5. Tramadol
      • 6.3.1.6. Oxycodone
      • 6.3.1.7. Others
    • 6.3.2. Stimulants
      • 6.3.2.1. Amphetamine
      • 6.3.2.2. Methylphenidate
      • 6.3.2.3. Dextroamphetamine
      • 6.3.2.4. Methamphetamine
      • 6.3.2.5. Modafinil
      • 6.3.2.6. Others
    • 6.3.3. Depressants
      • 6.3.3.1. Barbiturates
      • 6.3.3.2. Benzodiazepines
    • 6.3.4. Cannabinoids
  • 6.4. Market Attractiveness, by Drug

7. Global Controlled Substance Market Analysis and Forecasts, by Application, 2017-2027

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2027
    • 7.3.1. ADHD
    • 7.3.2. Pain Management
    • 7.3.3. Depression
    • 7.3.4. Sleep Disorder
    • 7.3.5. Cough Suppression
    • 7.3.6. Anxiety
    • 7.3.7. Seizure
    • 7.3.8. Others
  • 7.4. Market Attractiveness, by Application

8. Global Controlled Substance Market Analysis and Forecasts, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2027
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness, by Application

9. Global Controlled Substance Market Analysis and Forecasts, by Region, 2017-2027

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness, by Region

10. North America Controlled Substance Market Analysis and Forecast, 2017-2027

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Drug, 2017-2027
    • 10.2.1. Opioids
      • 10.2.1.1. Codeine
      • 10.2.1.2. Morphine
      • 10.2.1.3. Fentanyl
      • 10.2.1.4. Hydrocodone
      • 10.2.1.5. Tramadol
      • 10.2.1.6. Oxycodone
      • 10.2.1.7. Others
    • 10.2.2. Stimulants
      • 10.2.2.1. Amphetamine
      • 10.2.2.2. Methylphenidate
      • 10.2.2.3. Dextroamphetamine
      • 10.2.2.4. Methamphetamine
      • 10.2.2.5. Modafinil
      • 10.2.2.6. Others
    • 10.2.3. Depressants
      • 10.2.3.1. Barbiturates
      • 10.2.3.2. Benzodiazepines
    • 10.2.4. Cannabinoids
  • 10.3. Market Value Forecast, by Application, 2017-2027
    • 10.3.1. ADHD
    • 10.3.2. Pain Management
    • 10.3.3. Depression
    • 10.3.4. Sleep Disorder
    • 10.3.5. Cough Suppression
    • 10.3.6. Anxiety
    • 10.3.7. Seizure
    • 10.3.8. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2027
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast, by Country, 2017-2027
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Drug
    • 10.6.2. By Application
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Controlled Substance Market Analysis and Forecast, 2017-2027

  • 11.1. Introduction
    • 11.1.1. Key Finding
  • 11.2. Market Value Forecast, by Drug, 2017-2027
    • 11.2.1. Opioids
      • 11.2.1.1. Codeine
      • 11.2.1.2. Morphine
      • 11.2.1.3. Fentanyl
      • 11.2.1.4. Hydrocodone
      • 11.2.1.5. Tramadol
      • 11.2.1.6. Oxycodone
      • 11.2.1.7. Others
    • 11.2.2. Stimulants
      • 11.2.2.1. Amphetamine
      • 11.2.2.2. Methylphenidate
      • 11.2.2.3. Dextroamphetamine
      • 11.2.2.4. Methamphetamine
      • 11.2.2.5. Modafinil
      • 11.2.2.6. Others
    • 11.2.3. Depressants
      • 11.2.3.1. Barbiturates
      • 11.2.3.2. Benzodiazepines
    • 11.2.4. Cannabinoids
  • 11.3. Market Value Forecast, by Application, 2017-2027
    • 11.3.1. ADHD
    • 11.3.2. Pain Management
    • 11.3.3. Depression
    • 11.3.4. Sleep Disorder
    • 11.3.5. Cough Suppression
    • 11.3.6. Anxiety
    • 11.3.7. Seizure
    • 11.3.8. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2027
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2027
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Drug
    • 11.6.2. By Application
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Controlled Substance Market Analysis and Forecast, 2017-2027

  • 12.1. Introduction
    • 12.1.1. Key Finding
  • 12.2. Market Value Forecast, by Drug, 2017-2027
    • 12.2.1. Opioids
      • 12.2.1.1. Codeine
      • 12.2.1.2. Morphine
      • 12.2.1.3. Fentanyl
      • 12.2.1.4. Hydrocodone
      • 12.2.1.5. Tramadol
      • 12.2.1.6. Oxycodone
      • 12.2.1.7. Others
    • 12.2.2. Stimulants
      • 12.2.2.1. Amphetamine
      • 12.2.2.2. Methylphenidate
      • 12.2.2.3. Dextroamphetamine
      • 12.2.2.4. Methamphetamine
      • 12.2.2.5. Modafinil
      • 12.2.2.6. Others
    • 12.2.3. Depressants
      • 12.2.3.1. Barbiturates
      • 12.2.3.2. Benzodiazepines
    • 12.2.4. Cannabinoids
  • 12.3. Market Value Forecast, by Application, 2017-2027
    • 12.3.1. ADHD
    • 12.3.2. Pain Management
    • 12.3.3. Depression
    • 12.3.4. Sleep Disorder
    • 12.3.5. Cough Suppression
    • 12.3.6. Anxiety
    • 12.3.7. Seizure
    • 12.3.8. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2027
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2027
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Drug
    • 12.6.2. By Application
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Controlled Substance Market Analysis and Forecast, 2017-2027

  • 13.1. Introduction
    • 13.1.1. Key Finding
  • 13.2. Market Value Forecast, by Drug, 2017-2027
    • 13.2.1. Opioids
      • 13.2.1.1. Codeine
      • 13.2.1.2. Morphine
      • 13.2.1.3. Fentanyl
      • 13.2.1.4. Hydrocodone
      • 13.2.1.5. Tramadol
      • 13.2.1.6. Oxycodone
      • 13.2.1.7. Others
    • 13.2.2. Stimulants
      • 13.2.2.1. Amphetamine
      • 13.2.2.2. Methylphenidate
      • 13.2.2.3. Dextroamphetamine
      • 13.2.2.4. Methamphetamine
      • 13.2.2.5. Modafinil
      • 13.2.2.6. Others
    • 13.2.3. Depressants
      • 13.2.3.1. Barbiturates
      • 13.2.3.2. Benzodiazepines
    • 13.2.4. Cannabinoids
  • 13.3. Market Value Forecast, by Application, 2017-2027
    • 13.3.1. ADHD
    • 13.3.2. Pain Management
    • 13.3.3. Depression
    • 13.3.4. Sleep Disorder
    • 13.3.5. Cough Suppression
    • 13.3.6. Anxiety
    • 13.3.7. Seizure
    • 13.3.8. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2027
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast by Country/Sub-region, 2017-2027
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Drug
    • 13.6.2. By Application
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Controlled Substance Market Analysis and Forecast, 2017-2027

  • 14.1. Introduction
    • 14.1.1. Key Finding
  • 14.2. Market Value Forecast, by Drug, 2017-2027
    • 14.2.1. Opioids
      • 14.2.1.1. Codeine
      • 14.2.1.2. Morphine
      • 14.2.1.3. Fentanyl
      • 14.2.1.4. Hydrocodone
      • 14.2.1.5. Tramadol
      • 14.2.1.6. Oxycodone
      • 14.2.1.7. Others
    • 14.2.2. Stimulants
      • 14.2.2.1. Amphetamine
      • 14.2.2.2. Methylphenidate
      • 14.2.2.3. Dextroamphetamine
      • 14.2.2.4. Methamphetamine
      • 14.2.2.5. Modafinil
      • 14.2.2.6. Others
    • 14.2.3. Depressants
      • 14.2.3.1. Barbiturates
      • 14.2.3.2. Benzodiazepines
    • 14.2.4. Cannabinoids
  • 14.3. Market Value Forecast, by Application, 2017-2027
    • 14.3.1. ADHD
    • 14.3.2. Pain Management
    • 14.3.3. Depression
    • 14.3.4. Sleep Disorder
    • 14.3.5. Cough Suppression
    • 14.3.6. Anxiety
    • 14.3.7. Seizure
    • 14.3.8. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2017-2027
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2027
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Drug
    • 14.6.2. By Application
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Position/Ranking Analysis by Company (2018)
  • 15.3. Company Profiles
    • 15.3.1. F. Hoffmann-La Roche AG
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Company Financials
      • 15.3.1.3. Growth Strategies
      • 15.3.1.4. SWOT Analysis
    • 15.3.2. AbbVie, Inc.
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Company Financials
      • 15.3.2.3. Growth Strategies
      • 15.3.2.4. SWOT Analysis
    • 15.3.3. Mallinckrodt plc
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Company Financials
      • 15.3.3.3. Growth Strategies
      • 15.3.3.4. SWOT Analysis
    • 15.3.4. Pfizer, Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Company Financials
      • 15.3.4.3. Growth Strategies
      • 15.3.4.4. SWOT Analysis
    • 15.3.5. Sun Pharmaceutical Ltd.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Company Financials
      • 15.3.5.3. Growth Strategies
      • 15.3.5.4. SWOT Analysis
    • 15.3.6. Ampac Fine Chemicals
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Company Financials
      • 15.3.6.3. Growth Strategies
      • 15.3.6.4. SWOT Analysis
    • 15.3.7. GW Pharmaceuticals plc
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Company Financials
      • 15.3.7.3. Growth Strategies
      • 15.3.7.4. SWOT Analysis
    • 15.3.8. Merck & Co., Inc.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Company Financials
      • 15.3.8.3. Growth Strategies
      • 16.3.8.4. SWOT Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.